DNA & Genetics Challenging Pfizer, Novo Nordisk Offers Up-to-$9B for MetseraBy adminOctober 31, 20250 Intent on growing its leading position in obesity and weight management drugs, Novo Nordisk has made an unsolicited, approximately up-to-$9…
DNA & Genetics Novo Nordisk Raises MASH Bet with Up-to-$5.2B Akero AcquisitionBy adminOctober 14, 20250 If developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) were a poker game, you could say Novo Nordisk (NASDAQ Copenhagen: NOVO-B)…
Probiotics Health giants Novonesis and Novo Nordisk partner on microbiome innovationBy adminSeptember 18, 20250 Danish biosolutions company Novonesis and healthcare company Novo Nordisk have entered a research partnership to explore the role of the…
Probiotics Novo Nordisk And Novonesis Team Up For Dietary Supplements DevelopmentBy adminSeptember 9, 20250 The Danish firms plan to develop and test synbiotic dietary supplements – combining probiotics and prebiotics – that can have…
